Fractal analysis - A new approach in brain receptor imaging

Annals of Medicine

Volumn 30, Issue 3, 1998, Pages 242-248

  Kuikka, Jyrki ^a   Tiihonen, Jari ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Brain; Fractals; Positron emission tomography; Receptor; Single photon emission tomography

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; BRAIN RECEPTOR; HALOPERIDOL; OLANZAPINE; RADIOPHARMACEUTICAL AGENT;

DRUG RECEPTOR BINDING; FRACTAL ANALYSIS; HUMAN; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031777271     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809005851     Document Type: Review

References (25)

1. Kuikka JT, Belliveau JW, Hari R. Future of functional brain imaging. Eur J Nucl Med 1996; 23: 737-40.
2. Farde L. The advantage of using positron emission tomography in drug research. Trends Neurosci 1996; 19: 211-4.
3. Andreasen NC. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science 1997; 275: 1586-93.
4. Krishnan KRR, Doraiswamy PM. Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker; 1997.
5. Grabowski TJ, Damasio AR. Improving functional imaging techniques: the dream of a single image for a single mental event. Proc Natl Acad Sci USA 1996; 93: 14302-3.
6. 1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res 1991; 554: 56-64.
7. Stöcklin G. Tracers for metabolic imaging of brain and heart. Eur J Nucl Med 1992; 19: 527-51.
8. Pike VW. European concerted action on "New radiotracers for quality assurance for nuclear medicine applications". Eur J Nucl Med 1997; 24: BP15-9.
9. Lassen NA. A reappraisal of the relative merits of SPET and PET in the quantitation of neuroreceptors: the advantage of a longer half-life! Eur J Nucl Med 1996; 23: 1-4.
10. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plössl K, Lee HK. Imaging of dopamine transporters in humans with technetium-99m Trodat-1. Eur J Nucl Med 1996; 23: 1527-30.
11. Silbersweig DA, Stern E, Frith C, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995; 378: 176-9.
12. Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-7.
13. 2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558-63.
14. 11C]raclopride. Arch Gen Psychiatry 1990; 47: 213-9.
15. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 1994; 51: 116-23.
16. Hietala J, Syvälahti E, Vuorio K, et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346: 1130-1.
17. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extra-pyramidal side effects. Arch Gen Psychiatry 1992; 49: 538-44.
18. Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634-6.
19. Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW. Limbic selectivity of clozapine. Lancet 1997; 350:490-1.
20. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994; 116: 285-90.
21. Volkow ND, Wang GJ, Fowler JS, et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594-8.
22. Tiihonen J, Kuikka J, Bergström K, et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med 1995; 1: 654-7.
23. Tiihonen J, Kuikka JT, Bergström KA, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997; 24: 1253-9.
24. Tiihonen J, Kuikka J, Bergström K, Lepola U, Koponen H, Leinonen E. Dopamine re-uptake site densities in patients with social phobia. Am J Psychiatry 1997; 154: 239-42.
25. Schlegel S, Steinert H, Bockish A, Hahn K, Schlocsser R, Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by Iomazenil SPECT. Eur Arch Psychiatry Clin Neurosci 1994; 244: 49-51.